News
Centralised fund: pharma sector urges govt to let it utilise 1% of profit on in-house R&D activities
While the government is striving hard to boost exports to achieve sustainable economic growth, the pharmaceutical ...
Less than two weeks after the Senate moved to create a new prescription drug price cap system in Massachusetts, an industry official warned against legislative “leapfrog” that could ...
The “MAHA” movement sought to protect “medical freedom,” but its approach is far from libertarian.
The president’s proposed 25 percent tariffs on pharmaceutical imports will be catastrophic. There are other options to bring ...
In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...
Digital Banking platform CaixaBank research highlights that the growth of services sustains the dynamism of the economy in ...
Tobacco-funded research is still appearing in highly-cited medical journals - despite attempts by some to cut ties altogether ...
Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry, and its leaders are ...
But this doesn’t mean that any alternative is necessarily better. Some are proving to be demonstrably worse. J. D. Vance ...
Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
Dividend growth investing focuses on acquiring stocks that consistently increase their dividends, providing investors with a reliable, inflation-beating income stream and potential capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results